Hemophilia Drugs Market 2019 Analysis, Exhibit 6.0% CAGR and Remarkable Growth Rate forecast till 2025

Hemophilia Drugs Market is projected for better diagnosis because patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process, Hemophilia Drugs Industry exhibit a 6.0% & strong growth in the coming years

pune, india - May 16, 2019 /MarketersMedia/ —

The Global Hemophilia Drugs Market covered a value of US$ 9875.4 Mn in the year 2017 and is anticipated to reach US$ 15830.3 Mn by 2025. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. The above information was published in a report, titled “Hemophilia Drugs Market Size, Share and Global Trend by Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025.”

The rising prevalence of severe diseases is one of the major concerns in the healthcare industry. Among these disorders, patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process. Companies are introducing novel hemophilia drugs and therapies to fulfil the unmet needs of patients and maintain their quality of life. A lead analyst at Fortune Business Insights said, “Companies are building expansion strategies to develop new hemophilia drugs so as to offer better diagnosis.”

Among disease indications, hemophilia A is projected to exhibit a strong growth in the coming years. In addition to this, this segment covered a share of 85% in the global hemophilia drugs market in 2017. This is mainly attributable to the rising pool patients suffering from hemophilia across the world. Also, rising initiatives at developing and commercializing new products for the effective treatment of hemophilia is driving this segment’s growth. Following hemophilia A, hemophilia B drugs are also expected to grow at a considerable rate in the years to come.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemophilia-drugs-market-100068

Asia Pacific to Grow at a Rapid Pace with Rising Number of Hemophilia Patients

North America is projected to emerge dominant in the global hemophilia drugs market during the forecast period. This is mainly ascribable to the rising prevalence of hemophilia A and B, especially in countries such as Canada and the U.S. Moreover, in 2017, North America market for hemophilia drugs covered a value of US$ 3,684.7 Mn. Trailing North America, Europe is the second-leading region in the global hemophilia drugs market. The growth in this region is attributable to the rising healthcare budgets by governments and initiatives by governments to promote hemophilia drugs treatment. On the other hand, the hemophilia drugs market in Asia Pacific is likely to expand at a higher CAGR between 2017 and 2025 on account of rising number of patients suffering from hemophilia especially in countries such as China and India.

Rising Awareness About Hemophilia to Augment the Demand

The primary factor augmenting the hemophilia drugs market is the recent developments in hemophilia treatment. A lead analyst at Fortune Business Insights said “Several new drugs are expected to enter the global market in the coming years.” Also, hemophilia surgical management is gaining traction on account of increasing awareness about hemophilia across the world. Moreover, governments are planning to conduct awareness initiatives to spread knowledge regarding the use of hemophilia treatment and drugs This, in turn, is expected to drive the hemophilia drugs market over the next few years. The genetic evolution is leading to rising incidences of bleeding disorders across the world. This will further lead to hemophilia drug development in the next few years to come. As per the study conducted by the National Hemophilia Foundation or NHF in 2015, about 1% of the U.S. population is likely to suffer from a disease called von Willebrand, hence rising the need for hemophilia treatment drugs.

Pfizer Introduced Gene Therapy to Address Unmet Patient’s Needs

Some of the leading players presently operating in the global market for hemophilia drugs are Grifols SA, Bioverativ Inc., FERRING LÄKEMEDEL AB, Aptevo Therapeutics, Hoffmann-La Roche Ltd, Novo Nordisk, Pfizer, Inc. and CSL Behring. In 2018, companies such as Novo Nordisk, Takeda Pharmaceutical Company Ltd., and F. Hoffmann-La Roche Ltd covered more than half of the share in the global hemodialysis market as per revenue. In 2017, Pfizer, Inc. collaborated with Sangamo Therapeutics, Inc. to commercialize and develop gene therapy programs. The aim was to utilize these programs for Hemophilia A drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemophilia-drugs-market-100068

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemophilia-drugs-market-2019-analysis-exhibit-60-cagr-and-remarkable-growth-rate-forecast-till-2025/513243

Source: MarketersMedia

Release ID: 513243

More News From Enter Hollywood

Pell's appeal pitted word of former choirboy against priest

Aug 23, 2019

CANBERRA, Australia — Cardinal George Pell's appeal against his convictions for child molestation was largely a question of who the jury should have believed, his accuser or a senior priest whose church role was likened to Pell's bodyguard. Pell's accuser was a 13-year-old choirboy when he alleged that he was abused by then-Melbourne Archbishop Pell at the city's St. Patrick's Cathedral in December 1996 and February 1997. Monsignor Charles Portelli was a master of ceremonies at the 11 a.m. Sunday Masses where the choir sang. A chorister in the 1990s, David Dearing, told police that Portelli, Pell's right-hand man, was...

Chinese pop stars publicly back Beijing on Hong Kong

Aug 23, 2019

HONG KONG — At least eight pop stars from mainland China and one each from Taiwan and Hong Kong are publicly stating their support for Beijing's one-China policy, eliciting a mixture of disappointment and understanding from fans. Many of the statements came after protesters opposed to Beijing's growing influence over semi-autonomous Hong Kong removed a Chinese flag and tossed it into Victoria Harbour earlier this month. Lay Zhang, Jackson Wang, Lai Kuan-lin and Victoria Song were among the K-pop singers who recently uploaded a Chinese flag and declared themselves as "one of 1.4 billion guardians of the Chinese flag" on...

The Latest: Concerts canceled over Hong Kong airport protest

Aug 23, 2019

HONG KONG — The Latest on Hong Kong protests (all times local): 7 p.m. At least three concerts by overseas performers have been canceled in Hong Kong as protesters forced the city's airport to suspend operations for a second day. K-pop star Kang Daniel and Scottish band CHVRCHES both announced Tuesday that they are calling off upcoming events. American singer-songwriter Alec Benjamin canceled an upcoming concert late Monday. Kang's management office said the cancellation of a fan meeting scheduled for Sunday was because of safety concerns related to the protests, while CHVRCHES blamed "unforeseen circumstances." The airport protests are the...

China bans movies, actors from prominent Taiwan film awards

Aug 23, 2019

BEIJING — China said Wednesday it was banning Chinese movies and actors from participating in Taiwan's Golden Horse Awards, one of the Asian film industry's most prestigious honors, as Beijing ramps up economic and political pressure on the island it claims as its own territory. The one-sentence announcement on the microblog of China Film News, a newspaper affiliated with government film regulator, gave no reason for the suspension, but it comes amid rising tensions over Taiwan's refusal to recognize being part of Chinese territory to eventually be brought under Beijing's rule. Even without the ban, Chinese artists might have found...

Li Peng, Chinese premier during Tiananmen crackdown, dies

Aug 23, 2019

BEIJING — Li Peng, a former hard-line Chinese premier best known for announcing martial law during the 1989 Tiananmen Square pro-democracy protests that ended with a bloody crackdown by troops, has died. He was 90. China's official Xinhua News Agency said Li died Monday of an unspecified illness. His death was not announced until Tuesday evening. Li, a keen political infighter, spent two decades at the pinnacle of power before retiring in 2002. He left behind a legacy of prolonged and broad-based economic growth coupled with authoritarian political controls. While broadly disliked by the public, he oversaw China's reemergence from...

Sign up now!